Ontruzant 150 mg

Ontruzant 150 mg is a powder for solution used in intravenous therapy. It contains trastuzumab, a monoclonal antibody for targeted treatment. This medication is commonly used in cancer therapy.

Ontruzant 150 mg is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins on cancer cells, helping to slow or stop their growth. This medication is often prescribed for breast cancer and other conditions where trastuzumab is indicated. What is Ontruzant used for? It is used in cancer therapy to target and inhibit the growth of cancer cells.

Common effects of Ontruzant 150 mg may include fatigue, nausea, and fever. Some individuals might experience infusion reactions such as chills or shortness of breath. These effects vary and should be discussed with a healthcare provider.

Ontruzant 150 mg should be handled with care and prepared by a healthcare professional. It is important to follow proper storage and administration guidelines. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Ontruzant 150 mg may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.